Imfinzi Plus Neoadjuvant Chemo May Improve Surgery for Patients With NSCLC

Treatment with perioperative Imfinzi plus neoadjuvant chemotherapy may improve surgery outcomes for patients with resectable non-small cell lung cancer.

Related Keywords

Sayama ,Saitama ,Japan ,Osaka ,Singapore ,Tetsuya Mitsudomi ,National Institute Of Cancer ,Kindai University Faculty Of Medicine ,International Association ,Lung Cancer ,National Institute ,Kindai University Faculty ,News ,